Results 201 to 210 of about 447,676 (385)

Unstable Hemoglobin, a Rare but Significant Cause of Hemolytic Anemia: Recognition of Peripheral Smear Findings Is Crucial for Diagnosis

open access: yes
International Journal of Laboratory Hematology, EarlyView.
Ryan C. Shean   +2 more
wiley   +1 more source

Longitudinal metabolomics study of phosphate‐adenine‐guanosine‐glucose‐saline‐mannitol stored red blood cells

open access: yesTransfusion, EarlyView.
Abstract Background The storage of red blood cells (RBCs) is essential for transfusion but leads to storage lesions that compromise RBC quality and increase the risk of transfusion‐related adverse effects, including allergic transfusion reactions (ATRs). Understanding storage‐induced metabolic change is crucial for enhancing transfusion safety.
Gürkan Bal   +5 more
wiley   +1 more source

Hemolytic anemia in falciparum and vivax malarial patients based on serum bilirubin examination

open access: diamond, 2016
Yoyoh Yusroh   +5 more
openalex   +2 more sources

Identification of IV fluid contamination in complete blood counts and subsequent unnecessary red blood cell transfusions using artificial intelligence

open access: yesTransfusion, EarlyView.
Abstract Background Specimens contaminated with intravenous (IV) fluids can lead to considerable measurement errors in complete blood counts (CBCs), posing challenges for laboratory operations and clinical decision‐making. There is no gold‐standard method for retrospectively identifying these events, making it difficult to target quality improvement ...
Carly Maucione   +5 more
wiley   +1 more source

Successful Treatment of Refractory IgA-Mediated Autoimmune Hemolytic Anemia With Bortezomib. [PDF]

open access: yesEJHaem
Neri S   +8 more
europepmc   +1 more source

CLINICAL ASPECTS OF AUTOIMMUNE HEMOLYTIC ANEMIA IN CHILDREN (AIHA) [PDF]

open access: bronze, 1977
Ashok Shende   +2 more
openalex   +1 more source

Combination of low-dose rituximab, bortezomib and dexamethasone for the treatment of autoimmune hemolytic anemia

open access: gold, 2022
Mingkang Yao   +10 more
openalex   +1 more source

IgG4 anti‐CD47: Erythrophagocytosis and potential transfusion complications

open access: yesTransfusion, EarlyView.
Abstract Background IgG4 monoclonal anti‐CD47 for cancer immunotherapy resulted in anemia necessitating red cell (RBC) transfusions. Although the antibody readily binds to CD47 on RBCs, the mechanism underlying the anemia associated with IgG4 is poorly understood.
Kayluz Frias Boligan   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy